BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30872752)

  • 1. Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis.
    Hsu HM; Chu CM; Chang YJ; Yu JC; Chen CT; Jian CE; Lee CY; Chiang YT; Chang CW; Chang YT
    Sci Rep; 2019 Mar; 9(1):4484. PubMed ID: 30872752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
    Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
    Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.
    Kim EK; Park AK; Ko E; Park WY; Lee KM; Noh DY; Han W
    Breast Cancer Res Treat; 2019 Nov; 178(1):185-197. PubMed ID: 31342312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer.
    Suo HD; Tao Z; Zhang L; Jin ZN; Li XY; Ma W; Wang Z; Qiu Y; Jin F; Chen B; Cao Y
    Biomed Res Int; 2020; 2020():7575862. PubMed ID: 32766313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
    Yoshikawa K; Ishida M; Yanai H; Tsuta K; Sekimoto M; Sugie T
    PLoS One; 2020; 15(11):e0242563. PubMed ID: 33201923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis.
    Guo J; Gong G; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2219-2228. PubMed ID: 28849078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel.
    Lim GB; Kim YA; Seo JH; Lee HJ; Gong G; Park SH
    BMC Cancer; 2020 Nov; 20(1):1052. PubMed ID: 33138797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in triple-negative breast cancer in relation to survival.
    Wang S; Beeghly-Fadiel A; Cai Q; Cai H; Guo X; Shi L; Wu J; Ye F; Qiu Q; Zheng Y; Zheng W; Bao PP; Shu XO
    Breast Cancer Res Treat; 2018 Aug; 171(1):199-207. PubMed ID: 29748761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series.
    Picornell AC; Echavarria I; Alvarez E; López-Tarruella S; Jerez Y; Hoadley K; Parker JS; Del Monte-Millán M; Ramos-Medina R; Gayarre J; Ocaña I; Cebollero M; Massarrah T; Moreno F; García Saenz JA; Gómez Moreno H; Ballesteros A; Ruiz Borrego M; Perou CM; Martin M
    BMC Genomics; 2019 Jun; 20(1):452. PubMed ID: 31159741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
    Chen J; Qian X; He Y; Han X; Pan Y
    J Cell Biochem; 2019 Oct; 120(10):16900-16912. PubMed ID: 31081967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
    Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
    Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer.
    Chou CW; Huang YM; Chang YJ; Huang CY; Hung CS
    Int J Med Sci; 2021; 18(12):2521-2531. PubMed ID: 34104083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
    Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
    Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer.
    Zhou Q; Ren J; Hou J; Wang G; Ju L; Xiao Y; Gong Y
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2383-2396. PubMed ID: 31280346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis.
    Wushou A; Jiang YZ; Hou J; Liu YR; Guo XM; Shao ZM
    Breast Cancer Res Treat; 2015 Nov; 154(1):57-62. PubMed ID: 26476726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the BAD pathway is a marker of triple-negative status and poor outcome.
    Boac BM; Abbasi F; Ismail-Khan R; Xiong Y; Siddique A; Park H; Han M; Saeed-Vafa D; Soliman H; Henry B; Pena MJ; McClung EC; Robertson SE; Todd SL; Lopez A; Sun W; Apuri S; Lancaster JM; Berglund AE; Magliocco AM; Marchion DC
    Sci Rep; 2019 Nov; 9(1):17496. PubMed ID: 31767884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.